Skip to content

Early resuscitation effect of traumatic shock by endovascular balloon occlusion of the aorta (REBOA): A multi-center clinical study

Early resuscitation effect of traumatic shock by endovascular balloon occlusion of the aorta (REBOA): A multi-center clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105641
Enrollment
Unknown
Registered
2025-07-08
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic shock

Interventions

Experimental group:REBOA operation with "life-saving balloon" + standard anti-shock treatment
Control group:Standard anti-shock treatment.

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Either gender, aged over 18 years old; 2. Patients with a main diagnosis of severe traumatic shock; 3. Family members are informed, sign the informed consent form and agree to participate in the trial; 4. Systolic blood pressure <= 80 mmHg or/and mean arterial pressure <= 60 mmHg, and the patient has non-compressible massive hemorrhage in the trunk and/or the pelvi-abdominal junction; 5. There is no obvious injury in the femoral artery or brachial artery, allowing the doctor to complete the arterial puncture or/and incision operation; 6. Whether the patient has ever been or is still receiving cardiopulmonary resuscitation; 7. Patients in shock who continue to receive resuscitative measures such as chest compressions and artificial respiration for more than 10 minutes, yet remain unresponsive or exhibit transient responsiveness followed by recurrent loss of consciousness;

Exclusion criteria

Exclusion criteria: 1. Cardiogenic shock and other non-traumatic shock; 2. Complicated with severe myocardial infarction, severe respiratory failure (type I or/and type II); 3. Severe craniocerebral trauma; 4. Definite bleeding of thoracic organs; 5. Subjects are participating in other drug or medical device clinical trials and have not yet completed the main research endpoints of that study; 6. Patients and their families refuse to enroll; 7. Patients who have been in shock and coma for over six hours upon arrival at the medical facility; 8. Other situations judged by the investigator as not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Survival status;whether Lower limb arterial embolism, thrombosis formation;

Secondary

MeasureTime frame
Technical success rate of balloon operation;in-hospital time length;event-free survival;blood pressure resuming time ;Secondary intervention rate;90-day postoperative survival rate??;72-hour resuscitation success rate;

Countries

China

Contacts

Public ContactLu Qingsheng

The First Affiliated Hospital of Naval Medical University

christine2022@newvascular.cn+86 139 1729 2504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026